Super housing ban could cost 40,000 homes

Premium Content

Switzer Report

Switzer Report leverages Australia's most experienced finance and markets team to provide more in-depth commentary and analysis that can benefit your portfolio. Take a free trial for yourself to find out.

Start Your Free Trial

Expert Stock Picks

Curated recommendations from our analysts

Model Portfolios

Follow our proven investment strategies

In-Depth Analysis

Detailed research on markets & sectors

The Latest from Switzer

Why copper will shine again
Switzer Report Subscriber Exclusive
Investing

Why copper will shine again

While this strategic metal was due for a pullback over the last few months after extraordinary gains last year, its fundamentals remain strong.

Tony Featherstone 2 Jul
Two good value small caps
Switzer Report Subscriber Exclusive
Investing

Two good value small caps

Here are two small-cap stocks that look to be very good buying at current prices.

James Dunn 2 Jul
“HOT” stock: Telix Pharmaceuticals (TLX)
Switzer Report Subscriber Exclusive
Investing

“HOT” stock: Telix Pharmaceuticals (TLX)

Michael Gable, Managing Director of Fairmont Equities, explains why Telix Pharmaceuticals (TLX) is trending higher again.

Maureen Jordan 2 Jul
Questions of the Week (2 July 2026)
Switzer Report Subscriber Exclusive
Investing

Questions of the Week (2 July 2026)

Are there any listed investment companies that just focus on resource stocks? What do the major brokers think of Woolworths? What are the limits in…

Paul Rickard 2 Jul

Join our newsletter community

Get the latest financial, business, and political expert commentary delivered to your inbox every weekday.

Investing

View All